USD
$0.00
(0.00%
)At Close (As of Sep 16, 2025)
$1.70B
Market Cap
-
P/E Ratio
-7.63
EPS
$69.36
52 Week High
$10.14
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$84M |
Total Revenue | $1.3M |
Cost Of Revenue | $85M |
Costof Goods And Services Sold | $85M |
Operating Income | -$176M |
Selling General And Administrative | $21M |
Research And Development | $72M |
Operating Expenses | $92M |
Investment Income Net | - |
Net Interest Income | $5.8M |
Interest Income | $5.8M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $233K |
Income Before Tax | -$170M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$170M |
Comprehensive Income Net Of Tax | - |
Ebit | -$176M |
Ebitda | -$176M |
Net Income | -$170M |
Field | Value (USD) |
---|---|
Total Assets | $215M |
Total Current Assets | $211M |
Cash And Cash Equivalents At Carrying Value | $190M |
Cash And Short Term Investments | $190M |
Inventory | - |
Current Net Receivables | $1.7M |
Total Non Current Assets | $4.1M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $19M |
Other Non Current Assets | - |
Total Liabilities | $51M |
Total Current Liabilities | $50M |
Current Accounts Payable | $3.6M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $3.3M |
Total Non Current Liabilities | $1.9M |
Capital Lease Obligations | $3.6M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $3.6M |
Other Current Liabilities | $17M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $163M |
Treasury Stock | - |
Retained Earnings | -$611M |
Common Stock | $1K |
Common Stock Shares Outstanding | $6.3M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$177M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $233K |
Capital Expenditures | $129K |
Change In Receivables | - |
Change In Inventory | $6.1M |
Profit Loss | - |
Cashflow From Investment | -$129K |
Cashflow From Financing | $337M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$170M |
Field | Value (USD) |
---|---|
Gross Profit | -$84M |
Total Revenue | $1.3M |
Cost Of Revenue | $85M |
Costof Goods And Services Sold | $85M |
Operating Income | -$176M |
Selling General And Administrative | $21M |
Research And Development | $72M |
Operating Expenses | $92M |
Investment Income Net | - |
Net Interest Income | $5.8M |
Interest Income | $5.8M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $233K |
Income Before Tax | -$170M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$170M |
Comprehensive Income Net Of Tax | - |
Ebit | -$176M |
Ebitda | -$176M |
Net Income | -$170M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Cidara Therapeutics, Inc., a biotechnology company, is focused on the discovery, development, and commercialization of new long-acting anti-infectives for the treatment and prevention of disease in the United States. The company is headquartered in San Diego, California.